Radiation Dosimetry
ID: 75A50125R00001Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEBARDA - ASPR / DAAPPO / BARDA DCMAWASHINGTON, DC, 20515, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

COMMUNITY AND REGIONAL DEVELOPMENT R&D SERVICES; COMMUNITY DEVELOPMENT; BASIC RESEARCH (AB11)

Original Source

https://sam.gov/opp/9a451c1c6a7b428fb2eb34bd7c81cf94/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Biomedical Advanced Research and Development Authority (BARDA), is seeking proposals for the development of standardized radiation dosimetry guidelines for nonclinical models used in radiation research. The primary objective is to create harmonized dosimetry practices across BARDA's research portfolio, which is crucial for ensuring consistent and comparable data in medical countermeasures against various threats, including chemical, biological, radiological, and nuclear hazards. This five-year contract includes a two-year base period with three optional one-year extensions, and it requires comprehensive services such as irradiator assessments and the fabrication of phantoms for animal models. Interested vendors should submit their proposals, including detailed organizational information and past performance documentation, by the specified deadlines, with the estimated award date projected for the third quarter of fiscal year 2025. For further inquiries, contact Audrey Glover at audrey.glover@hhs.gov or Joann Kambaja at Joann.Kambaja@hhs.gov.

    Point(s) of Contact
    Audrey Glover
    audrey.glover@hhs.gov
    Joann Kambaja, Contract Specialist
    Joann.Kambaja@hhs.gov
    Files
    Title
    Posted
    75A50125R00001 RADNUC Solicitation.docx
    The document outlines a Request for Proposal (RFP) issued by the Biomedical Advanced Research and Development Authority (BARDA) within the Department of Health and Human Services. The overarching goal is to develop standardized radiation dosimetry guidelines applicable to nonclinical models for research institutions collaborating on medical countermeasures (MCMs) related to chemical, biological, radiological, and nuclear threats. Specifically, the RFP seeks to harmonize dosimetry methodology across BARDA’s research portfolio through a two-year base contract with an option for three one-year extensions, totaling five years. The contractor is expected to provide comprehensive services, including irradiator assessments and the development of phantoms for radiation experiments in diverse animal models. The proposal includes distinct contract line-item numbers for the base and option periods, outlining cost-plus-fixed-fee payments. Key deliverables encompass a catalog of available phantoms, a comprehensive inventory of irradiators, technical reports, and a quality management system plan. The document emphasizes the importance of collaboration, technical expertise, and detailed reporting for the success of the dosimetry harmonization initiative.
    75A50125R00001 RADNUC Solicitation -Amendment 1.docx
    The document outlines a Request for Proposal (RFP) for the Biomedical Advanced Research and Development Authority (BARDA) to develop standardized radiation dosimetry guidelines for nonclinical models. This initiative is essential for harmonizing dosimetry practices across BARDA's radiation research portfolio, facilitating consistent and comparable data for medical countermeasures against chemical, biological, radiological, and nuclear threats, as well as emerging infectious diseases. The overarching goal is to create source-independent dosimetry methods, requiring services such as fabricating phantoms for various animal models and conducting irradiator assessments. The contract encompasses a five-year performance period, segmented into a two-year base period with three optional one-year extensions. Financial arrangements highlight a cost-plus-fixed-fee structure for both base and option periods. Key deliverables include a catalog of phantoms, inventory assessments of irradiators, and periodic progress reports. Offerors must adhere to strict communication protocols and provide regular documentation to ensure compliance with safety and performance standards. This RFP serves the broader mission of enhancing public health preparedness by advancing research capabilities and uniformly assessing radiation exposure in research settings.
    Solicitation Questions. Answers.xlsx
    The Radiation Dosimetry Solicitation #75A50125R00001 seeks proposals for a project that involves the dosimetry evaluation of radiators in various facilities. The proposal is aimed at a single vendor to meet all specified requirements while assessing approximately six facilities in the base period with potential additions of 2-3 facilities each subsequent year. Participants must demonstrate proficiency through past performance information with a focus on specific contracts relevant to the Principal Investigator (PI). Key elements to be submitted include an organization chart, curriculum vitae (CV) of key personnel, and completion of Attachment 14, a past performance questionnaire. Budget considerations emphasize that costs should be laid out separately for each Contract Line Item Number (CLIN), with an Excel template provided to guide submissions. Clarifications regarding contract structure indicate a cost-reimbursement framework with a fixed fee linked to milestones. Potential contractors are advised that the estimated award date is projected for the third quarter of fiscal year 2025. Overall, the solicitation requires detailed organizational information and a clear understanding of the costs relative to the services provided to fulfill Department of Health and Human Services (HHS) expectations effectively.
    Lifecycle
    Title
    Type
    Radiation Dosimetry
    Currently viewing
    Solicitation
    Similar Opportunities
    Development of Radiation/Nuclear Medical Countermeasures (MCMs) And Biodosimetry Devices
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and biodosimetry devices. The primary objectives are to create MCMs that mitigate normal tissue injuries from ionizing radiation and to advance biodosimetry methods to enhance triage and treatment during radiation emergencies, with each proposal focusing on one of these goals. This initiative is crucial for national preparedness against potential radiological incidents, as it aims to improve the response to radiation exposure and associated health risks. Proposals are due by March 19, 2025, and interested parties must register in the System for Award Management (SAM); the estimated cost and fixed fee for the contract are to be determined. For further inquiries, contact Albert Nguyen at nguyenal@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov.
    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.
    BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Office of Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003, which focuses on innovative medical countermeasures (MCMs) to enhance public health preparedness against various threats, including infectious diseases and chemical agents. The initiative invites submissions across multiple Areas of Interest (AOIs), including but not limited to vaccine innovations, diagnostic technologies, and therapeutic solutions for acute radiation syndrome and chemical threats. This opportunity is critical for advancing biomedical research and developing effective responses to health emergencies, with multiple awards anticipated based on scientific merit and funding availability. Interested parties must register on SAM.gov and submit their abstracts by specified deadlines, with key submission dates ranging from March 15, 2024, to May 31, 2024, depending on the AOI. For further inquiries, respondents can contact Aarati Singal or Lara Emmons at DRIVeAcquisitions@hhs.gov.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY25 Broad Agency Announcement (BAA) aimed at advancing regulatory science and innovation. This opportunity invites organizations, particularly small businesses, to submit research and development proposals that address critical areas such as alternative drug development methods, advanced manufacturing technologies, and predictive toxicology, with a strong emphasis on including diverse populations in research. Proposals must be submitted by February 24, 2025, and will undergo a two-tier evaluation process, with the potential for multiple contracts awarded based on proposal quality and funding availability. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    2026 NIAID DMID Omnibus Broad Agency Announcement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the 2026 DMID Omnibus Broad Agency Announcement (BAA) aimed at advancing research and development of medical countermeasures against antimicrobial-resistant pathogens and viruses with pandemic potential. The BAA encompasses two primary research areas: the development of therapeutics, vaccines, and diagnostics for antimicrobial-resistant bacterial and fungal pathogens, and the creation of direct-acting antivirals for viral families of pandemic potential. This initiative is critical for addressing public health challenges related to infectious diseases and enhancing biodefense capabilities. Proposals for Research Area 001 are due by February 21, 2025, while those for Research Area 002 are due by January 21, 2025. Interested parties can reach out to primary contact Swee L. Teo at teosl@niaid.nih.gov or 240-669-5173 for further information.
    National Institute of Environmental Health Sciences (NIEHS) Assessment of Immunotoxicity – In Vitro and In Vivo Assessment of Immune Function
    Active
    Health And Human Services, Department Of
    The National Institute of Environmental Health Sciences (NIEHS), part of the Department of Health and Human Services, is seeking proposals for a federal contract focused on the assessment of immunotoxicity through in vitro and in vivo evaluation of immune function. The objective is to provide comprehensive research services to evaluate how selected test agents may modulate immune responses, utilizing both established and innovative methodologies to reduce animal use in toxicology studies. This contract, anticipated to be a cost-plus-fixed-fee type, is expected to be awarded by September 2025, with a base period of one year and nine optional one-year extensions. Interested parties should direct inquiries to Adam Muhsin at adam.muhsin@nih.gov and monitor the Sam.gov website for the solicitation release, which is expected no sooner than 15 days from this notice.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Active
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    BARDA DRIVe EZ-BAA-22-100-SOL-00003
    Active
    Health And Human Services, Department Of
    Solicitation: HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking proposals for BARDA DRIVe EZ-BAA-22-100-SOL-00003. This procurement is for health research and development services, health care services, and experimental development. The announcement serves as a reissuance of the BARDA DRIVe EZ-BAA and supersedes prior iterations. For more information, please visit https://drive.hhs.gov/.
    Sources Sought for Examining Dose Assessment, Atmospheric Dispersion & Environmental Transport, and Emergency Response & Protective Actions
    Active
    Nuclear Regulatory Commission
    The U.S. Nuclear Regulatory Commission (NRC) is conducting a Sources Sought Synopsis to identify qualified vendors capable of supporting the Radiation Protection Computer Code Analysis and Maintenance Program (RAMP). The primary objective is to find organizations that can perform research and development in areas such as Dose Assessment, Atmospheric Dispersion & Environmental Transport, and Emergency Response & Protective Actions, which are critical for maintaining and improving NRC-sponsored radiation protection and dose assessment computer codes. These services are essential for ensuring the safety and regulatory compliance of nuclear facilities, particularly in light of lessons learned from past incidents like Fukushima. Interested vendors must submit their capabilities and relevant experience by January 9, 2025, to Jeffrey Mitchell at Jeffrey.Mitchell@nrc.gov, as there is no solicitation at this time.
    FY2025-2034 DTRA Chemical and Biological Technologies Fundamental Research Broad Agency Announcement
    Active
    Dept Of Defense
    The Defense Threat Reduction Agency (DTRA) is inviting proposals for the FY2025-2034 Chemical and Biological Technologies Fundamental Research Broad Agency Announcement (BAA), aimed at advancing research to counter Weapons of Mass Destruction (WMD). This opportunity emphasizes collaborative efforts from accredited universities, industrial entities, and not-for-profit research organizations, focusing on innovative solutions in chemical and biological defense, including detection, diagnostics, and countermeasures against C-WMD threats. The BAA is crucial for enhancing national security and promoting STEM education, with funding anticipated for approximately 30 awards each year, ranging from $25,000 to $1 million annually. Interested applicants must submit pre-application white papers by February 7, 2024, and can contact the DTRA RD-CB FRBAA Mailbox at dtra.belvoir.rd.mbx.rd-cb-frbaa25-34-ta1@mail.mil for further information.